BNT162b2

Physician’s Briefing Staff TUESDAY, Sept. 6, 2022 (HealthDay News) -- The risk estimate for myocarditis in the 30 days after receipt of a COVID-19 booster dose (BNT162b2) is 1.42 per 100,000 overall,…

The joint study by Kaiser Permanente Southern California and Pfizer underscores the importance of improving Covid-19 vaccination rates worldwide and monitoring vaccine effectiveness to determine which populations should be prioritised to…